Indo Thai Securities Limited (NSE:INDOTHAI)

Verve Therapeutics Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	78.91	159.27	-64.84	99.28	101.63
Depreciation & Amortization, Total	6.12	5.32	5.24	6.11	7.61
Gain (Loss) On Sale of Investments	-83.36	-189.71	72.59	-122.56	-152.31
Change in Accounts Receivable	-106.46	-49.05	-2.13	8.86	73.34
Change in Accounts Payable	10.42	-36.41	-3.13	195.94	47.4
Change in Other Net Operating Assets	-45.26	32.67	-26.22	-13.07	-20.05
Other Operating Activities	-67.98	-12.54	-53.16	-16.28	47.25
Operating Cash Flow	-214.96	-27.46	13.49	48.78	43.64
Capital Expenditures	-4.01	-21.83	-4.08	-14.87	-11.18
Investment in Securities	-822.88	21.15	-31.44	-94.83	30.08
Other Investing Activities	75.32	34.93	19.77	24.44	18.77
Investing Cash Flow	-752.8	34.25	-15.75	-85.26	37.67
Short-Term Debt Issued	-	26.32	16.36	12.5	-
Long-Term Debt Issued	-	-	-	-	4.42
Total Debt Issued	-	26.32	16.36	12.5	4.42
Short-Term Debt Repaid	-25.42	-	-	-	-67.14
Total Debt Repaid	-25.42	-	-	-	-67.14
Net Debt Issued (Repaid)	-25.42	26.32	16.36	12.5	-62.72
Issuance of Common Stock	991.86	-	-	-	-
Common Dividends Paid	-6	-16	-10	-10	-
Other Financing Activities	-11.72	-8.79	-2.34	-8.54	-8.36
Financing Cash Flow	948.73	1.53	4.01	-6.04	-71.08
Net Cash Flow	-19.03	8.32	1.76	-42.52	10.23
Free Cash Flow	-218.96	-49.29	9.42	33.92	32.46
Free Cash Flow Growth	-	-	-72.24%	4.50%	-75.29%
Free Cash Flow Margin	-87.02%	-15.97%	12.56%	17.90%	15.36%
Free Cash Flow Per Share	-2.08	-0.49	0.09	0.34	0.33
Cash Interest Paid	11.72	8.79	2.34	8.54	8.36
Cash Income Tax Paid	29.08	24.17	11.03	12.66	1.33

Updated Jan 25, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.